149 related articles for article (PubMed ID: 36618916)
1. Flecainide and risk of skin neoplasms: Results of a large nested case-control study in Spain and Denmark.
Reyes C; León-Muñoz LM; Pistillo A; Jóhannesdóttir Schmidt SA; Kristensen KB; Puente D; LLorente-García A; Huerta-Álvarez C; Pottegård A; Duarte-Salles T
Front Pharmacol; 2022; 13():1002451. PubMed ID: 36618916
[No Abstract] [Full Text] [Related]
2. Use of hydrochlorothiazide and risk of skin cancer in a large nested case-control study in Spain.
León-Muñoz LM; Duarte-Salles T; Llorente A; Díaz Y; Puente D; Pottegård A; Montero-Corominas D; Huerta C
Pharmacoepidemiol Drug Saf; 2021 Sep; 30(9):1269-1278. PubMed ID: 34015159
[TBL] [Abstract][Full Text] [Related]
3. Risk of non-melanoma skin cancer in myasthenia patients treated with azathioprine.
Pedersen EG; Pottegård A; Hallas J; Friis S; Hansen K; Jensen PE; Gaist D
Eur J Neurol; 2014 Mar; 21(3):454-8. PubMed ID: 24330255
[TBL] [Abstract][Full Text] [Related]
4. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
Baandrup L
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
[TBL] [Abstract][Full Text] [Related]
5. Tranexamic acid use is not associated with the risk of melanoma in Danish women: A nested case-control study using Danish health registries.
Bønnelykke-Behrndtz ML; Kristensen KB; Hölmich LR; Pottegård A
Cancer Epidemiol; 2023 Jun; 84():102356. PubMed ID: 36996688
[TBL] [Abstract][Full Text] [Related]
6. Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease.
Long MD; Martin CF; Pipkin CA; Herfarth HH; Sandler RS; Kappelman MD
Gastroenterology; 2012 Aug; 143(2):390-399.e1. PubMed ID: 22584081
[TBL] [Abstract][Full Text] [Related]
7. Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case-control study.
Pottegård A; Pedersen SA; Schmidt SAJ; Lee CN; Hsu CK; Liao TC; Shao SC; Lai EC
Br J Cancer; 2019 Nov; 121(11):973-978. PubMed ID: 31673105
[TBL] [Abstract][Full Text] [Related]
8. The influence of immunosuppressants on the non-melanoma skin cancer among patients with systemic lupus erythematosus and primary Sjögren's syndrome: a nationwide retrospective case-control study in Taiwan.
Tseng HW; Huang WC; Lu LY
Clin Exp Rheumatol; 2019; 37(6):946-952. PubMed ID: 31074727
[TBL] [Abstract][Full Text] [Related]
9. Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark.
Pedersen SA; Gaist D; Schmidt SAJ; Hölmich LR; Friis S; Pottegård A
J Am Acad Dermatol; 2018 Apr; 78(4):673-681.e9. PubMed ID: 29217346
[TBL] [Abstract][Full Text] [Related]
10. Risk of skin cancer in patients with diabetes mellitus: A nationwide retrospective cohort study in Taiwan.
Tseng HW; Shiue YL; Tsai KW; Huang WC; Tang PL; Lam HC
Medicine (Baltimore); 2016 Jun; 95(26):e4070. PubMed ID: 27368048
[TBL] [Abstract][Full Text] [Related]
11. Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease.
Long MD; Herfarth HH; Pipkin CA; Porter CQ; Sandler RS; Kappelman MD
Clin Gastroenterol Hepatol; 2010 Mar; 8(3):268-74. PubMed ID: 20005977
[TBL] [Abstract][Full Text] [Related]
12. Is there a Link between Non Melanoma Skin Cancer and Hydrochlorothiazide?
Gallelli L; Cione E; Siniscalchi A; Vasta G; Guerra A; Scaramuzzino A; Longo L; Muraca L; De Sarro G; G Sp Working Group ; Leuzzi G; Gerace A; Scuteri A; Vasapollo P; Natale V; Zampogna S; Luciani F
Curr Drug Saf; 2022; 17(3):211-216. PubMed ID: 34732119
[TBL] [Abstract][Full Text] [Related]
13. Risk of skin cancer in patients on chronic haemodialysis: a nationwide, population-based study in Taiwan.
Wang CC; Tang CH; Wang CY; Huang SY; Sue YM
Br J Dermatol; 2016 Dec; 175(6):1175-1182. PubMed ID: 27273242
[TBL] [Abstract][Full Text] [Related]
14. Risk of melanoma and non-melanoma skin cancer in ulcerative colitis patients treated with thiopurines: a nationwide retrospective cohort.
Abbas AM; Almukhtar RM; Loftus EV; Lichtenstein GR; Khan N
Am J Gastroenterol; 2014 Nov; 109(11):1781-93. PubMed ID: 25244964
[TBL] [Abstract][Full Text] [Related]
15. Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners.
Teulings HE; Overkamp M; Ceylan E; Nieuweboer-Krobotova L; Bos JD; Nijsten T; Wolkerstorfer AW; Luiten RM; van der Veen JP
Br J Dermatol; 2013 Jan; 168(1):162-71. PubMed ID: 23136900
[TBL] [Abstract][Full Text] [Related]
16. Non-melanoma skin cancer and risk of Alzheimer's disease and all-cause dementia.
Schmidt SA; Ording AG; Horváth-Puhó E; Sørensen HT; Henderson VW
PLoS One; 2017; 12(2):e0171527. PubMed ID: 28225789
[TBL] [Abstract][Full Text] [Related]
17. Risk of Second Primary Cancer in People with Non-melanoma Skin Cancer: A Nationwide Cohort Study.
Wang SH; Chi CC; Zhao ZH; Tung TH
Cancer Res Treat; 2018 Apr; 50(2):428-435. PubMed ID: 28494532
[TBL] [Abstract][Full Text] [Related]
18. Chronic diseases requiring hospitalization and risk of non-melanoma skin cancers--a population based study from Denmark.
Jensen AØ; Olesen AB; Dethlefsen C; Sørensen HT; Karagas MR
J Invest Dermatol; 2008 Apr; 128(4):926-31. PubMed ID: 17914446
[TBL] [Abstract][Full Text] [Related]
19. Use of antiepileptic drugs and risk of skin cancer: A nationwide case-control study.
Kristensen KB; Pedersen SA; Schmidt SAJ; Pottegård A
J Am Acad Dermatol; 2020 Feb; 82(2):326-335. PubMed ID: 31150714
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]